Drugs
-
Exenatide (marketed as Byetta) Information
Byetta (exenatide) is approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program using the contact information at the bottom of this page.
-
Related Information
Byetta Safety Update for Healthcare Professionals
11/9/2009Information for Healthcare Professionals: Reports of Altered Kidney Function in patients using Exenatide (Marketed as Byetta)
11/2/2009Information for Healthcare Professionals: Exenatide (marketed as Byetta) - 8/2008 Update
8/18/2008Information for Healthcare Professionals: Exenatide (marketed as Byetta) - 10/2007
-
-
Labeling and Regulatory History from Drugs@FDA
-
-
-